Skip to main content
. Author manuscript; available in PMC: 2013 Nov 11.
Published in final edited form as: Breast Cancer Res Treat. 2011 Oct 25;133(2):10.1007/s10549-011-1811-9. doi: 10.1007/s10549-011-1811-9

Table 4.

Mammary progenitor cell markers

Prepubertal (a) Adolescent (b) Adult luteal (c) Pregnant (d) Lactating (e) Postmenopausal (f) Pairwise comparisons Padj < 0.05
ELF5 1.00 1.22 10.59 9.16 12.87 2.35 a, b, f vs. c-e
CD24 1.00 1.09 1.66 1.21 3.97 1.59 a vs. b-f
e vs. b-d, f
STAT5 1.00 1.17 2.81 5.96 1.68 1.14 a vs. b-f
b vs. d
c, f vs. d, e
d vs. e
ALDH1 1.00 1.10 1.38 −1.36 1.47 1.19 a vs. b-f
b vs. d
d vs. e, f
DICER 1.00 −1.23 −1.25 −2.25 −4.02 −1.20 a vs. b-f
b, c vs. d, e
d vs. e, f
e vs. f
RIF1 1.00 −1.37 −1.29 −2.44 −4.49 −1.44 a vs. b-f
b, c vs. d, e
e vs. f
BMPR1A 1.00 −1.12 −1.14 −1.56 −1.56 −1.16 a vs. b-f
b vs. d
c, f vs. d, e
TGFB2 1.00 −1.40 −1.17 −3.99 −6.23 −1.22 a vs. b-f
b, c, f vs. d, e
CD44 1.00 −1.09 −1.30 −2.99 −5.09 −1.15 a vs. b-f
b vs. d, e
c vs. e
CD29 1.00 1.00 −1.24 −1.85 −4.86 −3.86 a vs. b-f
b, c, f vs. d, e
FOXA1 1.00 −1.04 −1.76 −2.28 −2.42 −1.44 a vs. b-f
b, c, f vs. d, e
KLF4 1.00 1.05 1.61 −2.76 −4.19 1.51 a vs. b-f
b vs. c-e
c, f vs. d, e
NOTCH2 1.00 1.17 1.19 −1.58 −2.37 1.11 a vs. b-f
b, c vs. d, e
d vs. e, f
e vs. f
LIG4 1.00 −1.12 1.37 −2.03 −4.09 1.12 a vs. b-f
b vs. c-e
c vs. d, e
d vs. e, f
e vs. f
BRCA1 1.00 1.11 1.06 −1.18 −1.68 −1.22 a vs. b-f
e vs. b-d, f
POSTN 1.00 1.16 −10.06 −28.27 −92.92 −9.17 a vs. b-f
b vs. d-f
c, d vs. e
e vs. f
IGF1 1.00 1.28 −2.46 −2.22 −8.22 −2.28 a vs. b-f
b vs. d-f
e vs. c, d
e vs. f
CD61 1.00 −1.07 1.20 −1.20 1.27 −1.20 a vs. b-f
e vs. b-d, f

Up- and down-regulated overlapping genes within life stage groups being significantly different from prepubertal animals at P < 0.05. Pairwise comparisons at Padj < 0.05 were made, and the relevant results are presented in the text